(PFE) Pharma and Biotech Stock Outlook – August 2012 – Industry Outlook
The pharmaceutical industry is in the midst of one of the biggest patent cliffs with Pfizer’s (PFE) multi-billion-dollar blockbuster drug Lipitor losing patent protection in the US in late November...
View Article(MRK) Pharmaceuticals and Biotech Stock Outlook – December 2012 – Industry...
The pharmaceutical industry is slowly showing signs of recovery from one of the biggest patent cliffs in recent times. The last few quarters saw major blockbusters like Merck’s (MRK) Singulair,...
View Article(CBST) Cubist Pharmaceuticals Sees Encouraging News From FDA
Recently, Cubist Pharmaceuticals Inc. (CBST) received some encouraging news when the US Food and Drug Administration (FDA) designated its antibiotic candidate CXA-201 (ceftolozane/tazobactam) as a...
View Article(ACAS) American Capital’s Earnings and Revenues Lag
American Capital Ltd. (ACAS) reported first-quarter 2013 operating income of 14 cents per share, lagging the Zacks Consensus Estimate by 14 cents. Moreover, the results compared unfavorably with the...
View Article
